Listing Announcement of Bio Protocol (BIO) dan GateToken (GT)
2025-01-03Hi Bittimers,
Bittime has listed Bio Protocol (BIO) and GateToken GT. Trading is available today, November 7th, 2024.
About Bio Protocol (BIO)
BIO is the native token of the BIO Protocol platform, a DeFi-based biotech platform. Bio Protocol enables the world's scientists, investors, it’s token holders to participate in the development of science and biotechnology. Both in terms of funding, supporting the tokenization of scientific intellectual property (IP), managing the platform, and accessing early investment opportunities in biotechnology projects. Based on Ethereum, BIO offers a solution for biotechnology projects that are often constrained, while supporting a more prosperous Decentralized Science (DeSci) ecosystem.
Listing Detail:
- Coin : BIO
- Deposit Open : January 3th, 2024
- Trade Open : January 3th, 2024
- Trading Pairs : BIO
About GateToken (GT)
GateToken (GT) is the native utility token of the Gate.io exchange platform and GateChain blockchain. GT serves as the “fuel” of the GateChain ecosystem and is used to pay transaction fees, and can be staked. In addition, GT holders can enjoy various benefits on the Gate.io platform, such as discounts on transaction fees, upgraded VIP status, and access to new project airdrops. This token plays an important role in supporting the infrastructure and services offered by Gate.io and GateChain.
Listing Detail:
- Coin : GT
- Deposit Open : January 3th, 2024
- Trade Open : January 3th, 2024
- Trading Pairs : GT/IDR
Learn More With Bittime:
- Collection of educational articles about blockchain, web3 and crypto HERE
- Find out what to ask about Bittime HERE
- How to Buy Crypto Assets HERE
Take the first step on your crypto journey with Bittime and download the Bittime application here:
- Register a Bittime account: Download here
- iOS Users : Download here
- Android users: Download here
Find Bittime here:
- Instagram: @bittimexchange
- Twitter: @bittimexchange
- Telegram: @bittimexchange
Disclaimer: The views expressed belong exclusively to the author and do not reflect the views of this platform. This platform and its affiliates disclaim any responsibility for the accuracy or suitability of the information provided. It is for informational purposes only and not intended as financial or investment advice.